Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
32.02
-0.98 (-2.97%)
Nov 13, 2026, 10:01 AM EST - Market open
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year. That makes Definium Therapeutics the 31,102nd largest employer in the world and 3,971st in the United States.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$3,183,783
Market Cap
4.38B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Cogent Biosciences | 258 |
| Relay Therapeutics | 218 |
| Disc Medicine | 173 |
DFTX News
- 1 day ago - Psychedelic: Definium Therapeutics narrows quarterly net loss - TheFly
- 2 days ago - Definium Therapeutics reports Q3 EPS (46c), consensus (56c) - TheFly
- 2 days ago - Definium Therapeutics price target raised to $70 from $66 at RBC Capital - TheFly
- 3 days ago - Definium Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 3 days ago - Definium Therapeutics Slides: Corporate presentation - Filings
- 3 days ago - Definium Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Definium Therapeutics Earnings release: Q3 2026 - Filings
- 3 days ago - Definium Therapeutics Quarterly report: Q3 2026 - Filings